Evidence-Based Decision-Making 2: Systematic Reviews and Meta-Analysis
- PMID: 33871856
- DOI: 10.1007/978-1-0716-1138-8_22
Evidence-Based Decision-Making 2: Systematic Reviews and Meta-Analysis
Abstract
The number of studies published in the biomedical literature has dramatically increased over the last few decades. This massive proliferation of literature makes clinical medicine increasingly complex, and information from multiple studies is often needed to inform a particular clinical decision. However, available studies often vary in their design, methodological quality, and population studied, and may define the research question of interest quite differently. This can make it challenging to synthesize the conclusions of multiple studies. In addition, since even highly cited trials may be challenged over time, clinical decision-making requires ongoing reconciliation of studies which provide different answers to the same question. Because it is often impractical for readers to track down and review all the primary studies, systematic reviews and meta-analyses are an important source of evidence on the diagnosis, prognosis and treatment of any given disease. This chapter summarizes methods for conducting and reading systematic reviews and meta-analyses, as well as describes potential advantages and disadvantages of these publications.
Keywords: Forest plot; Literature synthesis; Meta-analysis; Random effects; Systematic review.
References
-
- National Institutes of Health (2018) Detailed Indexing Statistics: 1965–2017. https://www.nlm.nih.gov/bsd/index_stats_comp.html . Accessed 6 Nov 2019
-
- National Institutes of Health (2016) Fact sheet: The National Library of Medicine. http://wayback.archive-it.org/org-350/20180312141403/https://www.nlm.nih... . Accessed 5 Nov 2019
-
- Ioannidis JP (2005) Contradicted and initially stronger effects in highly cited clinical research. J Am Med Assoc 294:218–228 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
